Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO Preconditioning in Aortic Valve Surgery
NCT01727167Phase 2Terminated
- Start
- Feb 2014
- Primary completion
- Jan 2016
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Carbon monoxide in aortic valve disease (AVD) (2 arms). Primary endpoint: Biochemical Markers for Mitochondrial Biogenesis (Blood and Right Atrial Tissue) at 2 weeks. Started Feb 2014; status: terminated.
02
Drugs
Carbon monoxide
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on NCT01727167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01727167.